Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TGTX

TG Therapeutics Inc

Dec 24 • 04:00PM ET

32.16

Dollar change -0.10
Percentage change -0.31	%

Healthcare • Biotechnology • USA • NASD

Peers: BLUE GILD RARE JAZZ NBIX SRPT AKBA PTCT AUPH XOMA

| Held by: IJR VTI IWM VB XBI VXF VBK IWO IJT SPSM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.11	Insider Own	9.74%	Shs Outstand	155.78M	Perf Week	-2.32%
Market Cap	5.01B	Forward P/E	33.37	EPS next Y	0.96	Insider Trans	-0.33%	Shs Float	140.50M	Perf Month	-6.50%
Income	-14.36M	PEG	-	EPS next Q	0.08	Inst Own	65.43%	Short Float	20.70%	Perf Quarter	40.43%
Sales	264.79M	P/S	18.91	EPS this Y	-58.33%	Inst Trans	7.56%	Short Ratio	9.91	Perf Half Y	84.94%
Book/sh	1.23	P/B	26.07	EPS next Y	2470.00%	ROA	-3.13%	Short Interest	29.08M	Perf Year	92.88%
Cash/sh	2.19	P/C	14.68	EPS next 5Y	-	ROE	-8.05%	52W Range	12.84 - 36.84	Perf YTD	91.98%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-3.23%	52W High	-12.70%	Beta	2.23
Dividend TTM	-	Quick Ratio	3.91	Sales past 5Y	2506.46%	Gross Margin	88.20%	52W Low	150.47%	ATR (14)	1.79
Dividend Ex-Date	-	Current Ratio	4.59	EPS Y/Y TTM	51.39%	Oper. Margin	-0.19%	RSI (14)	53.86	Volatility	5.57% 5.08%
Employees	264	Debt/Eq	1.32	Sales Y/Y TTM	39.53%	Profit Margin	-5.42%	Recom	1.33	Target Price	40.75
Option/Short	Yes / Yes	LT Debt/Eq	1.31	EPS Q/Q	-96.70%	Payout	0.00%	Rel Volume	0.17	Prev Close	32.26
Sales Surprise	2.66%	EPS Surprise	-33.33%	Sales Q/Q	-49.41%	Earnings	Nov 04 BMO	Avg Volume	2.94M	Price	32.16
SMA20	-2.56%	SMA50	8.05%	SMA200	49.12%	Trades		Volume	496,456	Change	-0.31%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-24	Initiated	TD Cowen	Buy	$50
Aug-02-23	Upgrade	Goldman	Sell → Neutral	$16 → $12
Jun-26-23	Resumed	Jefferies	Buy	$55 → $40
May-20-22	Initiated	BofA Securities	Underperform	$5
Feb-23-22	Reiterated	B. Riley Securities	Buy	$49 → $35
Nov-15-21	Downgrade	Goldman	Neutral → Sell	$33 → $26
Apr-20-21	Initiated	Goldman	Neutral	$50
Apr-19-21	Reiterated	H.C. Wainwright	Buy	$79 → $89
Sep-01-20	Initiated	JP Morgan	Overweight	$38
Aug-11-20	Reiterated	H.C. Wainwright	Buy	$32 → $38
Jun-05-20	Initiated	Evercore ISI	Outperform	$60
Jan-17-20	Reiterated	H.C. Wainwright	Buy	$20 → $24
Nov-27-19	Resumed	B. Riley FBR	Buy	$12
Feb-06-19	Resumed	Jefferies	Buy	$8
Sep-25-18	Downgrade	Raymond James	Strong Buy → Outperform
Mar-09-18	Reiterated	B. Riley FBR, Inc.	Buy	$21.50 → $27
Dec-01-17	Resumed	B. Riley FBR, Inc.	Buy	$21.50
Nov-14-17	Resumed	H.C. Wainwright	Buy	$33
Apr-25-17	Initiated	Jefferies	Buy
Mar-06-17	Reiterated	FBR & Co.	Outperform	$24 → $26

Show Previous Ratings

Dec-24-24 10:58PM	Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? (Insider Monkey)
Nov-29-24 08:00AM	TG Therapeutics to Participate in the Evercore HealthCONx Conference (GlobeNewswire)
Nov-26-24 06:45AM	TG Therapeutics price target raised to $43 from $30 at JPMorgan (TipRanks)
Nov-21-24 12:35PM	TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook (GuruFocus.com) +10.91%
06:00AM	TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500 (GlobeNewswire)
02:02AM	Loading…
Nov-05-24 02:02AM	TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +6.16%
01:17AM	Q3 2024 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-04-24 04:15PM	AI Stocks Meta, Oracle Lead Five Names Near Buy Points (Investor's Business Daily) -9.44%
04:07PM	TG Therapeutics Crashes Reversing A Breakout After Missing 'Whisper' Expectations (Investor's Business Daily)
09:00AM	FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics (GlobeNewswire)
08:10AM	TG Therapeutics (TGTX) Lags Q3 Earnings Estimates (Zacks)
07:06AM	TG Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance (GlobeNewswire)
Nov-01-24 08:06AM	TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update (GlobeNewswire) +7.34%
Oct-31-24 03:44PM	Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025? (Insider Monkey)
12:38AM	Loading…
Sep-21-24 12:38AM	TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-18-24 04:20PM	IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug (Investor's Business Daily)
04:09PM	Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
03:29PM	Small-Cap Stocks Lead Volatile Action After Fed's Half-Point Rate Cut; Meta, Carpenter Near Buy Points, But Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
02:41PM	Indexes Turn Bullishly Higher On Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
01:44PM	Indexes Mixed Ahead Of Fed Decision, But Donald Trump Stock Slammed Again; Majority Of Magnificent Seven Stocks Fall (Live Coverage) (Investor's Business Daily)
12:28PM	Indexes Stall Ahead Of Fed Decision, Donald Trump Stock Slammed Again; Most Magnificent Seven Stocks Fall (Live Coverage) (Investor's Business Daily)
10:46AM	Indexes Move Quietly Ahead Of Fed Decision; Google Stock Rises 6th Straight Day On Victory In EU Spat (Live Coverage) (Investor's Business Daily)
07:15AM	New BRIUMVI (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis (GlobeNewswire)
07:00AM	New Data for BRIUMVI (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment (GlobeNewswire)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +7.81%
01:31PM	Four Biotech Stocks Rally Toward Buy Points As Funds Load Up (Investor's Business Daily)
Sep-05-24 07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting (GlobeNewswire)
Aug-30-24 10:38AM	TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory (Insider Monkey)
Aug-19-24 04:00PM	IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter (Investor's Business Daily) +14.09%
04:23PM	Loading…
Aug-16-24 04:23PM	IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability (Investor's Business Daily) +5.44%
Aug-12-24 04:32AM	FDA grants IND clearance for TG Therapeutics trial of multiple sclerosis treatment (Clinical Trials Arena)
Aug-06-24 04:00PM	TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157% (Investor's Business Daily) +19.58%
09:46AM	TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% (Investor's Business Daily)
08:15AM	TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:18AM	TG Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance (GlobeNewswire)
Aug-05-24 07:30AM	TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update (GlobeNewswire) -6.97%
Jul-12-24 01:22PM	Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves (Investor's Business Daily)
Jun-26-24 10:05AM	Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area (Investor's Business Daily) -7.61%
Jun-21-24 03:09AM	Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX) (GuruFocus.com)
Jun-11-24 08:45AM	Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises (GlobeNewswire)
Jun-07-24 07:50AM	TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 07:30AM	TG Therapeutics to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-31-24 07:30AM	TG Therapeutics Announces Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting (GlobeNewswire)
May-28-24 07:30AM	TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting (GlobeNewswire)
May-03-24 09:33AM	TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
05:56AM	Why TG Therapeutics Stock Was Rocketing Higher This Week (Motley Fool)
May-02-24 03:05AM	TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ... (GuruFocus.com)
12:27AM	Q1 2024 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-24 11:53AM	TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +16.25%
08:34AM	TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss (GuruFocus.com)
08:30AM	TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:32AM	TG Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 04:55PM	TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update (GlobeNewswire)
09:35AM	After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX) (Zacks)
Apr-27-24 09:37AM	10 Best Languages to Learn for the Future (Insider Monkey)
Apr-18-24 07:30AM	TG Therapeutics Announces Additional Data Presentations for BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
07:00AM	TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis (GlobeNewswire)
Apr-15-24 07:30AM	TG Therapeutics Announces Presentation of Data for BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
Mar-13-24 07:07AM	13 Best Biotech Stocks To Buy Under $20 (Insider Monkey)
Mar-08-24 07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting (GlobeNewswire) -6.78%
Mar-01-24 07:30AM	TG Therapeutics Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum (GlobeNewswire)
Feb-29-24 09:22AM	TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 10:24PM	Q4 2023 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +26.74%
04:05PM	TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? (Investor's Business Daily)
08:10AM	TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:52AM	TG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
07:21AM	TG Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results (GlobeNewswire)
Feb-27-24 07:30AM	TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI (ublituximab-xiiy) (GlobeNewswire)
Feb-26-24 07:00AM	TG Therapeutics Announces European Launch of BRIUMVI (ublituximab-xiiy) (GlobeNewswire)
Feb-23-24 07:30AM	TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update (GlobeNewswire)
Feb-20-24 10:00AM	Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know (Zacks)
07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum (GlobeNewswire)
Feb-13-24 07:20AM	Precision receives payments from TG Therapeutics for azer-cel (Pharmaceutical Business Review) -8.23%
Jan-22-24 06:30AM	7 Exciting Stocks Poised for Explosive Growth in Key Sectors (InvestorPlace) +7.63%
Jan-10-24 04:09PM	TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance (Investor's Business Daily) -15.42%
09:33AM	TG Therapeutics Adds To Its 225% Sprint After MS Drug Crushes Sales Estimates (Investor's Business Daily)
07:00AM	TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones (GlobeNewswire)
Jan-09-24 09:03AM	Director Laurence Charney Sells 17,500 Shares of TG Therapeutics Inc (GuruFocus.com)
07:00AM	TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision's Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases (GlobeNewswire)
Jan-06-24 05:02AM	Insider Sell: CFO Sean Power Sells 47,867 Shares of TG Therapeutics Inc (TGTX) (GuruFocus.com)
Jan-05-24 07:30AM	TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +9.05%
Dec-15-23 10:22AM	11 Most Promising Biotech Stocks to Buy According to Analysts (Insider Monkey)
Dec-07-23 03:31PM	TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating (Investor's Business Daily)
Nov-27-23 07:30AM	TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-06-23 09:55AM	Does TG Therapeutics (TGTX) Have the Potential to Rally 127.76% as Wall Street Analysts Expect? (Zacks) -7.32%
09:27AM	TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 07:30AM	TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference (GlobeNewswire) +6.24%
Nov-01-23 12:18PM	Why TG Therapeutics Stock Is Crushing It Today (Motley Fool) +30.92%
10:21AM	Morning Brew: AMD's Q4 Guidance Weighs on Stock, Apple's Negative Sentiment Overcooked, and Fed (GuruFocus.com)
09:17AM	TG Therapeutics Inc (TGTX) Reports Third Quarter 2023 Financial Results (GuruFocus.com)
07:43AM	TG Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 07:30AM	TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update (GlobeNewswire) +6.18%
Oct-14-23 01:15PM	13 Stocks to Buy with Exponential Growth (Insider Monkey)
Oct-12-23 11:00AM	TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting (GlobeNewswire)
Oct-11-23 10:30AM	TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting (GlobeNewswire)

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lonial Sagar	Director	Nov 11 '24	Sale	30.44	5,000	152,200	100,195	Nov 12 05:02 PM
Charney Laurence N	Director	Nov 11 '24	Sale	30.20	25,000	754,875	212,479	Nov 12 05:01 PM
Charney Laurence N	Director	Nov 11 '24	Proposed Sale	30.19	25,000	754,873		Nov 12 11:36 AM
Lonial Sagar	Director	Nov 11 '24	Proposed Sale	30.44	5,000	152,200		Nov 12 11:12 AM
Echelard Yann	Director	Nov 05 '24	Sale	24.48	20,000	489,600	224,098	Nov 07 04:35 PM
Echelard Yann	Director	Nov 05 '24	Proposed Sale	24.48	20,000	489,500		Nov 05 01:42 PM
Lonial Sagar	Director	Jun 20 '24	Sale	16.87	16,348	275,791	105,195	Jun 20 06:07 PM
Lonial Sagar	Director	Jun 17 '24	Sale	16.39	9,585	157,098	99,293	Jun 20 06:07 PM
Lonial Sagar	Director	Mar 13 '24	Sale	15.94	5,000	79,675	108,878	Mar 15 04:37 PM
Charney Laurence N	Director	Mar 12 '24	Sale	15.97	22,000	351,340	215,229	Mar 13 04:52 PM
Charney Laurence N	Director	Jan 05 '24	Sale	19.03	17,500	333,025	237,229	Jan 08 06:33 PM
Power Sean A	CFO	Jan 03 '24	Sale	16.91	47,867	809,431	606,969	Jan 05 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TGTX

TG Therapeutics Inc

Upgrade your FINVIZ experience